1250. Prevalence and Risk Factors for Acquiring Carbapenem-Resistant Enterobacteriaceae in an Intensive Care Unit at a Tertiary Hospital
Session: Poster Abstract Session: Healthcare Epidemiology: Outbreaks
Friday, October 5, 2018
Room: S Poster Hall
Background: Active surveillance testing of carbapenem-resistant Enterobacteriaceae (AST-CRE) is recommended in high-risk settings, such as intensive care units (ICUs), to prevent CRE outbreaks or invasive infections. This study aimed to investigate the effects of AST-CRE by analyzing the prevalence and risk factors for acquiring CRE during the ICU care.

Methods: We conducted AST-CRE on rectal swabs of patients admitted to the ICU in the emergency room at a tertiary hospital in South Korea for 12.5 months. AST-CRE was performed upon admission and weekly thereafter. To assess the risk factors of acquiring AST-CRE during the admission period in adult patients, those colonized with CRE upon admission and aged <18 years were excluded. AST-CRE was performed using Centers for Disease Control and Prevention methods. A polymerase chain reaction assay was performed to detect five carbapenemase genes (NDM, KPC, VIM, IMP, and OXA).

Results: A total of 810 patients were admitted during the study period. The acquisition rate and carbapenemase-producing CRE were 2.6% (21/810) and 42.9% (9/21), respectively. No invasive infection due to CRE was found. The most common species were Klebsiella pneumoniae (71.4%, 15/21), and eight KPC and one NDM genes were detected. In CRE-positive patients, in-hospital mortality and length of hospitalization were higher (P=0.003) and longer (P<0.001), respectively. Multivariate analyses showed that male gender (adjusted odds ratio [aOR] 8.0; 95% confidence interval [CI] 1.7-36.8), previous hospitalization in the last year (aOR 5.1; 95% CI 1.6-16.4), co-colonization with multidrug-resistant Acinetobacter species (aOR 18.3; 95% CI, 4.2-79.2) and extended-spectrum beta-lactamase-producing bacteria (aOR 3.4; 95% CI, 1.1-10.9), and length of ICU admission until CRE detection for ≥10 days (aOR 6.5; 95% CI 2.2-19.2) were independently associated with CRE acquisition.

Conclusion: To prevent CRE outbreak or invasive infections, patients admitted in the ICU should be screened using AST-CRE.

Jin Suk Kang, MD1, Soon Ok Lee, MD2, Jeong Eun Lee, MD2, So Ra Kim, RN3, Han Wool Kim, MT3, Seung Hyun Hong, RN3, Hye Won Kim, RN3, Mi Jin Jang, RN3, Sun Hea Shin, RN3, Hyun Jung Ha, RN3, Nam Jeong Park, RN3, Mee Kyung Ko, BS4, Jongyoun Yi, MD4 and Kye-Hyung Kim, MD2, (1)Internal Medicine, Inje University Busan Paik Hospital, Busan, Korea, Republic of (South), (2)Internal Medicine, Pusan National University Hospital, Busan, Korea, Republic of (South), (3)Infection Control, Pusan National University Hospital, Busan, Korea, Republic of (South), (4)Laboratory Medicine, Pusan National University Hospital, Busan, Korea, Republic of (South)

Disclosures:

J. S. Kang, None

S. O. Lee, None

J. E. Lee, None

S. R. Kim, None

H. W. Kim, None

S. H. Hong, None

H. W. Kim, None

M. J. Jang, None

S. H. Shin, None

H. J. Ha, None

N. J. Park, None

M. K. Ko, None

J. Yi, None

K. H. Kim, None

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.